Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: Correlation of protein expression with lymph node metastases and advanced clinical stage

Cancer

Volumn 79, Issue 6, 1997, Pages 1114-1121

  Fracchiolla, Nicola S ^a   Pruneri, Giancarlo ^a   Pignataro, Lorenzo ^a   Carboni, Nadia ^a   Capaccio, Pasquale ^a   Boletini, Alketa ^a   Buffa, Roberto ^a   Neri, Antonino ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

cyclin D1; gene amplification; laryngeal squamous cell carcinoma; protein expression

Indexed keywords

CYCLIN D1; DNA; ONCOPROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; DNA PURIFICATION; FEMALE; GENE LOCUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; CYCLINS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; ONCOGENE PROTEINS;

EID: 0030942852     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970315)79:6<1114::AID-CNCR9>3.0.CO;2-F     Document Type: Article

References (43)

1. Batsakis JG. Tumors of head and neck: clinical and pathological considerations. Baltimore: Williams and Wilkins, 1979: 574.
2. Johnson NW. Oro-facial neoplasms: global epidemiology, risk factors and recommendations for research. FDI Technical Report 36.London: Fèdèration Dentaire Internationale, 1990.
3. Goldsmith MM, Pillsbury HC. Pathologic and cytometric indicators of biologic behaviour in laryngeal cancer. In: Silver CE, editor. Laryngeal cancer. New York: Thieme Medical Publishers, 1991:27-32.
4. Sakai E, Rikimaru K, Ueda M, Matsumoto Y, Ishii N, Enomoto S, et al. The p53 tumor-suppressor gene and RAS oncogene mutations in oral squamous-cell carcinoma. Int J Cancer 1992;52:867-72.
5. Saranath D, Chang SE, Bhoite LT, Panchal RG, Kerr IB, Metha AR, et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 1991;63:573-8.
6. Somers KD, Cartwright SL, Schechter GL. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene 1990;5:925-30.
7. Berenson JR, Yang, J, Mickel RA. Frequent amplification of bcl-1 locus in head and neck carcinomas. Oncogene 1989; 4:1111-6.
8. lshitoya J, Toriyama M, Oguchi N, Kitamura K, Ohshima M, Asano K, et al. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br J Cancer 1989;59:559-62.
9. Leonard JH, Kearsley JH, Chenevix-Trench G, Hayward NK. Analysis of gene amplification in head and neck squamous cell carcinomas. Int J Cancer 1991;48:511-5.
10. Fracchiolla NS, Pignataro L, Capaccio P, Trecca D, Boletini A, Ottaviani A, et al. Multiple genetic lesions in laryngeal squamous cell carcinomas. Cancer 1995;75:1292-301.
11. Maestro R, Dolcetti R, Gasparotto D, Doglioni C, Pelucchi S, Barzan L, et al. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992;7:1159-66.
12. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-Type Cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 1995;55:949-56.
13. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-7.
14. Motokura T, Arnold A. Cyclins and oncogenesis. Biochim Biophys Acta 1993;1155:63-78.
15. Cordon-Cardo C. Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 1995;147:545-60.
16. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato J-D. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cel Biol 1994;14:2066-76.
17. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993;73:499-511.
18. Chen X, Bargonetti J, Prives C. p53, through p21 (WAF1/ CIP1), induces cyclin D1 synthesis. Cancer Res 1995;55:4257-63.
19. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995;10:775-8.
20. Rosemberg CL, Wong E, Petty EM, Bale AE, Tsujimoto Y, Harris NL, et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A 1991;88:9638-42.
21. Motokura T, Bloom T, Kim HG, Juppner H, Buderman JV, Kronenberg HM, et al. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 1991;350:512-5.
22. Lammie GA, Fantl V, Smith R, Schuuring E, Brooks S, Michalides R, et al. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to bcl-1. Oncogene 1991;8:439-44.
23. Jiang W, Kahan SM, Zhou P, Zhang YJ, Cacace AM, Infante AS, et al. Amplification and expression of the human cyclin D gene in esophageal cancer. Oncogene 1993;8:3447-57.
24. Jares P, Fernandez PL, Campo E, Nadal A, Bosch F, Aiza G, et al. PRAD-1/Cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994;54:4813-7.
25. Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, et al. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 1996;2:175-80.
26. Zhang Y-J, Jiang W, Chen CJ, et al. Amplification and overexpression of Cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun 1993;196:1010-6.
27. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994;57:353-61.
28. UICC. TNM classification of malignant tumors. Hermanek P, Sobin LH, editors.Berlin: Springer-Verlag, 1987.
29. Shanmugaratnam K, Sobin IN, and pathologists in 8 countries. Histologic typing of tumours of the upper respiratory tract and ear. Geneva: World Health Organization, 1991.
30. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC): a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-80.
31. Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 1985;315:340-3.
32. Williams ME, Meeker TC, Swerdlow SH. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood 1991; 78:493-8.
33. Ravetch JV, Siebenlist V, Korsmeyer SJ, Waldmann TA, Leder P. Structure of the immunoglobulin M locus: characterization of embryonic and rearranged J and D regions. Cell 1981;27:583-91.
34. Xu L, Davidson BJ, Murty VVVS, et al. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int J Cancer 1994;59:383-7.
35. Armitage P, Berry G. Statistical methods in medical research. Blackwell Scientific Publications, 1991:125-32.
36. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994;91:709-13.
37. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994;369:669-71.
38. Michalides R, van Veelen N, Hart A, Loftus B, Wientjens E, Balm A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
39. Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R, et al. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996; 73:728-34.
40. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993;7:812-21.
41. Quelle DE, Ashmun RA, Shurtleff SA, Kato J, Bar-Sagi D, Roussel MF, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993;7:1559-71.
42. Muller D, Millon R, Lidereau R, Engelmann, Bronner G, Flesch H, et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Oral Oncol Eur J Cancer 1994;30B:113-20.
43. Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FBJM, et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992;52:5229-34.